Celldex Therapeutics Inc

Research Celldex Therapeutics Inc (CLDX) on Bullrun: market cap USD 2.94B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCLDX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.94B
• Financial periodFY2025
• RevenueUSD 1.55M
• Revenue growth-78.0%
• Net income-USD 258.76M
• Free cash flow-USD 213.66M
• Gross margin87.1%

Valuation Snapshot

latest market cap is USD 2.94B.

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate.

Frequently asked questions

What is Celldex Therapeutics Inc's market cap?

Celldex Therapeutics Inc's market capitalization is USD 2.94B.

What does Celldex Therapeutics Inc do?

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.